๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies

โœ Scribed by O'Connor, O. A.; Stewart, A. K.; Vallone, M.; Molineaux, C. J.; Kunkel, L. A.; Gerecitano, J. F.; Orlowski, R. Z.


Book ID
119963720
Publisher
American Association for Cancer Research
Year
2009
Tongue
English
Weight
377 KB
Volume
15
Category
Article
ISSN
1078-0432

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES